Search results
Author(s):
Dario DiFrancesco
Added:
3 years ago
HCN4 (hyperpolarisation-activated, cyclic nucleotide gated 4) channels, the pore-forming α–subunits of ‘funny’ channels originally described in pacemaker cells of the sinoatrial node (SAN),1 are responsible for the early phase of diastolic depolarisation in these cells and are key determinants of pacemaker generation and control of heart rate.2–5 HCN4 channels are selectively expressed in the SAN…
View more
Author(s):
Demosthenes G Katritsis
,
Hugh Calkins
Added:
6 months ago
Author(s):
Demosthenes G Katritsis
Added:
3 years ago
The ideal pacing site in the ventricle(s) of patients with atrioventricular (AV) block has been debated for years. Despite considerable technological advances, the optimal ventricular pacing site to mimic normal human ventricular physiology and attain the best haemodynamic response remains elusive.1
Prolonged ventricular dyssynchrony induced by long-term right ventricular (RV) apical pacing is…
View more
The Promise of Leadless Pacing
Author(s):
Katrina Mountfort
,
Reinoud Knops
,
Johannes Sperzel
,
et al
Added:
3 years ago
Article
Author(s):
Parikshit S Sharma
Added:
2 years ago
In this video interview, Dr Parikshit Sharma (Rush University Medical Center, Chicago, IL, US) discusses the clinical outcomes from the Geisinger-Rush Conduction System Pacing Registry, presented at ESC's Heart Rhythm Society 2021. This was a non-randomized, observational cohort registry, which aimed to compare the results of left bundle branch area pacing compared to right ventricular pacing in…
View more
Author(s):
Mads Brix Kronborg
Added:
7 months ago
ESC 2023 — Dr Mads Brix Kronborg (Aarhus University Hospital, DE) joins us to discuss the findings from the DANPACE II Trial (NCT00236158).
DANPACE II (The DANPACE Investigator Group) trial aimed to compare patients who were randomised in a 1:1 ratio to either a base rate of 60 beats per minute and rate-adaptive DDD (DDDR-60 Group) or a base rate of 40bpm and non-rate adaptive DDD (DDD-40…
View more
Author(s):
Fatima M Ezzeddine
,
Isaac G Leon
,
Yong-Mei Cha
Added:
8 months ago
Author(s):
Alexandre Raymond-Paquin
,
Santosh K Padala
,
Kenneth A Ellenbogen
Added:
2 years ago
Author(s):
Henry Chubb
,
Mark O’Neill
,
Eric Rosenthal
Added:
3 years ago
Device therapy is increasingly employed in the management of complex congenital heart disease (CHD). Bradycardias, most often related to sinus nodal dysfunction (SND) or atrioventricular nodal (AVN) block, may necessitate the implantation of pacing devices, while malignant arrhythmias may be treated by appropriate use of implantable cardioverter defibrillators (ICDs). However, there is a complex…
View more